Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-01 @ 10:42 PM
Study NCT ID:
NCT05522335
Status:
UNKNOWN
Last Update Posted:
2022-08-31
First Post:
2022-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
Sponsor:
Bharat Biotech International Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-13
First Submit QC Date:
None
Study First Post Date:
2022-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-29
Last Update Post Date:
2022-08-31
Last Update Post Date Type:
ACTUAL